First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Alzheimer Disease · Frontotemporal Dementia · Dementia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

China Basin, UCSF, San Francisco, California, United States
Contact: Study coordinator (David Wilson, MD, PhD) · david.m.wilson@ucsf.edu

Study leads

David Wilson, MD, PhD
Principal Investigator
University of California, San Francisco

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Premorbid Personality Profile of Patients With Cognitive and Behavioral Disorders

Behavioral Variant of Frontotemporal Disorder (bvFTD) · Phenocopy Frontotemporal Dementia (phFTD) · Frontal Variant of Alzheimer Disease

Abroad (travel likely)Recruiting

Nantes, France

Dementia Caregivers' Link to Assistance and Resources

Alzheimer Disease or Associated Disorder · Dementia

Abroad (travel likely)Recruiting

New York, United States

Comprehensive Assessment of Neurodegeneration and Dementia

Dementia · Mild Cognitive Impairment (MCI) · Subjective Cognitive Impairment

Abroad (travel likely)Recruiting

Calgary, Canada · Edmonton, Canada

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

Alzheimer Disease · Dementia Alzheimers · Dementia

Abroad (travel likely)Recruiting

Belmont, United States